Medindia

X

IPOdesktop Releases Forterus Analyst Report, Includes CEO Interview

Friday, December 11, 2009 Corporate News J E 4
Advertisement


LOS ANGELES, Dec. 10 IPOdesktop.com releases updated analyst report for Forterus (Pink Sheets: FTER) that includes an audio interview with Forterus CEO Paul Howarth.

Forterus Analyst Report http://www.gaskinsco.com/linkto-fter.shtml

Includes this audio interview link http://gaskinsco.com/fter-12-4.mp3

About Forterus, Inc

Forterus provides a variety of healthcare services, including behavioral healthcare, intervention services, drug and alcohol rehabilitation, pain management and physical therapy.

For more information about Forterus and the variety of healthcare services it provides, including behavioral, intervention services, drug and alcohol rehabilitation, pain management and physical therapy, visit www.forterushealthcare.com

About http://IPOdesktop.com

IPOdesktop.com, the leading provider of independent IPO research for professional money managers and individual investors, also produces the IPO Hardball radio program. In the 'Analysts Corner' at IPOdesktop.com, research reports are available for both recent IPOs and emerging companies.

Disclaimer & Safe Harbor Statement

IPOdesktop (ID) SAFE HARBOR STATEMENT: Statements contained in this interview and research report, including those pertaining to estimates and related plans, potential mergers and acquisitions, estimates, growth, establishing new markets, expansion into new markets and related plans other than statements of historical fact, are forward-looking statements subject to a number of uncertainties that could cause actual results to differ materially from statements made. This report and interview is a paid advertisement. ID has been paid up to eighty five hundred dollars from the company. More safe harbor & disclaimer at http://gaskinsco.com/report-disclaimer-b.htm

Contact:Paul Howarth, CEO(888) 257-8345ir@forterus.com

SOURCE Forterus
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Ajinomoto Announces Amino Acid Initiative
S
ThermoGenesis Corp. Names Healthcare Industry Exec...